| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 63,755 | 64,759 | 62,943 | 57,726 | | Cost of Revenue | 13,046 | 13,576 | 14,122 | 15,729 | | | Gross Profit |
-
| 51,183 | 48,821 | 41,997 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 30,124 | 30,243 | 28,051 | 23,862 | | Non Recurring |
-
|
-
|
-
| (4,804) | | Others | 12,095 | 9,883 | 7,292 | 22,207 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 11,057 | 13,478 | 732 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | 8,490 | 11,057 | 13,478 | 732 | | Interest Expense | 4,219 | 4,533 | 4,590 | 5,184 | | Income Before Tax | 4,271 | 6,524 | 8,888 | (4,452) | | Income Tax Expense | 803 | 1,812 | 2,819 | (1,769) | | Minority Interest | 147 |
-
|
-
|
-
| | | | Net Income From Continuing Ops | 3,615 | 4,712 | 6,069 | (2,683) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 3,615 | 4,712 | 6,069 | (2,683) | | Preferred Stock And Other Adjustments | (1,439) | (1,292) | (1,277) | (178) | | | Net Income Applicable To Common Shares | $2,176 | $3,420 | $4,792 | ($2,861) |
|
0.31% Nasdaq 
0.05%
Income Statement
